? Indiana’s proposed ban on intoxicating hemp-derived THC products failed to meet its legislative deadline, preserving the status quo. For patients, this means continued access to products that many rely on for pain, sleep, and anxiety management, but it also means continued exposure to an unregulated marketplace. ️ The real clinical concern is not whether these products are available but whether they are safe, accurately labeled, and manufactured under proper quality controls. Legislators who let this bill die need to come back with a framework that protects consumers rather than simply choosing between a total ban and no regulation at all. In the meantime, I encourage all patients using hemp-derived THC products to seek out brands with third-party certificates of analysis and to discuss their use openly with their healthcare provider.